Join Now

iVeena Secures $3 Million in Series B-2 Financing to Accelerate Development of IVMED-85 for Myopia

By Natalie Themm | Published March 13, 2025

iVeena Secures $3 Million in Series B-2 Financing to Accelerate Development of IVMED-85 for Myopia

Posted in BioUtah News | Tagged | Comments Off on iVeena Secures $3 Million in Series B-2 Financing to Accelerate Development of IVMED-85 for Myopia

A Special Thanks To Our Legacy and Platinum Elite Members